Bernard Do

institut des sciences moleculaires

H指数:19

被引数:898

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hospital-Compounded Birabresib Capsules for NUT Carcinoma: A Quality- and Risk-Based CMC Strategy

医院复配的Birabresib胶囊用于NUT癌：一种基于质量和风险的CMC策略

Pharmaceutical Research

IF4.3

2026-03-250

OAAI

A Risk-Based, Qtpp-Driven Framework For Semi-Solid Extrusion 3d Printing of Personalized Medicines: Integrating Hospital Compounding and Clinical Trial Regulation

基于风险的、Qtpp驱动的个性化药物半固态挤出3d打印框架：整合医院混合配制和临床试验法规

European Journal of Pharmaceutical Sciences

IF4.7

2025-10-200

OAAI

HYBRID GPP–HOSPITAL CONTROL STRATEGY FOR SEMI-SOLID EXTRUSION 3D PRINTING OF ONC201 CHEWABLE UNITS IN PEDIATRIC ONCOLOGY

半固体挤出3D打印用于儿科肿瘤学中ONC201咀嚼单位的混合GPP–医院控制策略

European Journal of Pharmaceutical Sciences

IF4.7

2025-10-140

OAAI

A Risk-Based Framework for Hospital Compounding: Integrating Degradation Mechanisms and Predictive Toxicology

基于风险的方法用于医院配制：整合降解机制和预测毒理学

Pharmaceutics 2025, Vol. 17, Page 1202

IF5.5

2025-09-190

OAAI

Ensuring quality control in HME, a quantitative analysis of hydrocortisone filament using a portable Raman spectrometer

确保HME中的质量控制，对氢化可的松纤维进行定量分析，使用便携式拉曼光谱仪

Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy

IF4.6

2025-09-190

OAAI

Quality of antidiabetic medicines in 13 sub-Saharan African countries: a cross-sectional survey

13个撒哈拉以南非洲国家的抗糖尿病药物质量：一项横断面调查

eClinicalMedicine

IF10

2025-08-070

PREAI

Clinical implementation of a paediatric 3D-printed combination of Sulfamethoxazole and Trimethoprim

临床应用儿科3D打印磺胺甲噁唑和甲氧苄啶组合

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2025-05-010

OAAI

Development of a pediatric oral solution of ONC201 using nicotinamide to enhance solubility and stability

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2024-12-010

OAAI

Developing an innovative 3D printing platform for production of personalised medicines in a hospital for the OPERA clinical trial

在医院为OPERA临床试验开发用于生产个性化药物的创新3D打印平台

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2024-08-019

OAAI

Physicochemical Stability of Doravirine (Pifeltro®): Characterization of Main Degradation Products and Assessment of Stability of Tablets Repackaged in Single-Dose Unit Containers

PHARMACEUTICS

IF5.5

2024-07-240

OAAI

Molecular Mechanisms Involved in the Chemical Instability of ONC201 and Methods to Counter Its Degradation in Solution

PHARMACEUTICS

IF5.5

2023-09-223

OAAI

Identification of Degradation Products of the New Anticancer Drug Substance ONC201 by Liquid Chromatography-High-Resolution Multistage Mass Spectrometry

CHEMOSENSORS

IF3.7

2023-05-154

Development of carbon monoxide-releasing molecules conjugated to polysaccharides (glyco-CORMs) for delivering CO during obesity

开发与多糖 (glyco-corms) 结合的一氧化碳释放分子，以在肥胖期间释放CO

PHARMACOLOGICAL RESEARCH

IF10.5

2023-05-013

OAAI

3D-Printed, Liquid-Filled Capsules of Concentrated and Stabilized Polyphenol Epigallocatechin Gallate, Developed in a Clinical Trial

ANTIOXIDANTS

IF6.6

2023-02-092

OAAI

Identification of the Major Degradation Pathways of Selumetinib

PHARMACEUTICS

IF5.5

2022-11-303

OAAI

Unequal Behaviour between Hydrolysable Functions of Nirmatrelvir under Stress Conditions: Structural and Theoretical Approaches in Support of Preformulation Studies

PHARMACEUTICS

IF5.5

2022-08-178

OAAI

Mixed Polymeric Micelles for Rapamycin Skin Delivery

PHARMACEUTICS

IF5.5

2022-03-0417

OAAI

Simple Approach to Enhance Green Tea Epigallocatechin Gallate Stability in Aqueous Solutions and Bioavailability: Experimental and Theoretical Characterizations

PHARMACEUTICALS

IF4.8

2021-11-3012

OAAI

Ruxolitinib photodegradation mechanisms by theoretical and experimental chemistry

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2021-04-012

PREAI

Intrinsic stability of the antiviral drug umifenovir by stress testing and DFT studies

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2021-03-0110

OAAI

Bernard Do

个人简介

教育背景

工作经历

荣誉奖项

研究方向